Psyched Wellness - CEO and Director, Jeff Stevens.

" Psyched Wellness (CSE:PSYC) details path to U.S. market for AME-1 products

Psyched Wellness (PSYC) plans to launch its Amanita Muscaria products in the U.S. in Q2 2022.
The Market Herald Video

" Psyched Wellness announces the Amanita Muscaria mushroom has been added to the Natural Health Products Ingredients Database (NHPID) of Canada

Psyched Wellness (PSYC) announced that the Amanita Muscaria mushroom has been added to the Natural Health Products Ingredients Database (NHPID) of Canada.

" Psyched Wellness (CSE:PSYC) initiates a clinical sleep study

Psyched Wellness (PSYC) has initiated a clinical study of its AME-1 as a sleep-enhancing food supplement for self-declared insomniacs.

" Psyched Wellness (CSE:PSYC) partners with CannaLabs to begin stability tests on AME-1

Psyched Wellness (PSYC) has entered into a service agreement with CannaLabs.
Psyched Wellness - CEO and Director, Jeff Stevens.

" Psyched Wellness (CSE:PSYC) receives positive results from preclinical study

Psyched Wellness (PSYC) is reporting positive results from its oral toxicity preclinical study of AME-1, its proprietary Amanita Muscaria extract.

" Psyched Wellness (CSE:PSYC) welcomes Matthew Singh as CPG and branding consultant

Psyched Wellness is pleased to welcome Matthew Singh as a consultant to lead the go-to-market branding and sales strategy for its AME-1 derived

" Psyched Wellness (CSE:PSYC) commences next pre-clinical study on AME-1

Psyched Wellness (PSYC) and its CRO partner, KGK Science, have commenced a 90-day oral toxicity study of AME-1.

" Psyched Wellness (CSE:PSYC) to present at the H.C. Wainwright Conference

Psyched Wellness (PSYC) will be participating in the upcoming H.C. Wainwright’s Psychiatry and Beyond Virtual Conference on Thursday, June 17 2021.

" Psyched Wellness (CSE:PSYC) initiates the next pre-clinical trial study on AME-1

Psyched Wellness (PSYC) and its clinical research partner KGK Science have commenced the next preclinical trial study with AME-1.